Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

The role of immune responses and microbiota in adipose tissue homeostasis

Azar S., Rehermann B.

Narrative Review, published in J Physiol (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
J Physiol (2025)
Reported sample size
—
Source database
Europe PMC
PMID
41292129
PMCID
PMC12704045
DOI
10.1113/jp286422
Citations
1

Abstract (original English)

White and brown adipose tissue form a metabolic organ that plays a crucial role in regulating body energy homeostasis. Adipose tissue is richly vascularized and innervated to respond to a variety of environmental signals. Adipose tissue also contains diverse populations of innate and adaptive immune cells. These immune cells contribute to the regulation of adipose tissue function, and adipocytes in turn signal to immune cells in response to metabolic and environmental triggers. The gut microbiota have recently emerged as an additional factor that affects adipose tissue homeostasis. This can occur either directly via metabolites and bacterial products or indirectly via its effects on immune cells. Natural, co-evolved microbiota, if encountered in early postnatal life, have been shown to confer protection against obesity in later periods of life. The complexity of these factors and interactions warrants further investigation and may ultimately provide opportunities for therapeutic interventions that prevent obesity and metabolic disease.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adipose TissueAnimalsHumansObesityHomeostasisMicrobiotaGastrointestinal Microbiome

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.